Cargando…

Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer

Introduction: Breast cancer is the most common malignancy in women. Due to the large number of women living with breast cancer and the increasing incidence of this cancer, it is very important to understand the factors determining the quality of life (QOL) of patients. The aim of the study. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Konieczny, Magdalena, Cipora, Elżbieta, Roczniak, Wojciech, Babuśka-Roczniak, Magdalena, Wojtaszek, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696805/
https://www.ncbi.nlm.nih.gov/pubmed/33187071
http://dx.doi.org/10.3390/ijerph17228325
_version_ 1783615488063963136
author Konieczny, Magdalena
Cipora, Elżbieta
Roczniak, Wojciech
Babuśka-Roczniak, Magdalena
Wojtaszek, Marek
author_facet Konieczny, Magdalena
Cipora, Elżbieta
Roczniak, Wojciech
Babuśka-Roczniak, Magdalena
Wojtaszek, Marek
author_sort Konieczny, Magdalena
collection PubMed
description Introduction: Breast cancer is the most common malignancy in women. Due to the large number of women living with breast cancer and the increasing incidence of this cancer, it is very important to understand the factors determining the quality of life (QOL) of patients. The aim of the study. The aim of the study was to determine the impact of time to initiation of treatment on the quality of life of women with breast cancer. Materials and methods. The study involved 324 women with breast cancer, treated at the Podkarpackie Oncology Centre in Brzozów, Poland. The study was conducted using a diagnostic survey, using a standardised questionnaire to measure the quality of life of women treated for breast cancer, i.e., the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC) QLQ-C30 and the QLQ-BR23 module, as well as a proprietary survey questionnaire. Statistical analysis was performed using the Statistica 10.0 software (StatSoft Inc., 2011). A p value of <0.05 was considered statistically significant. Results: The examined women had a reduced overall quality of life and health (M = 53.88). The quality of life was higher in women who consulted a doctor the earliest after noticing initial symptoms of the disease, i.e., up to one week (M = 57.58), compared to patients who delayed the decision (over four weeks; M = 47.8) (p = 0.002). The quality of life was also considered higher by women who received treatment within two weeks of diagnosis (M = 56.79) and was lower for patients who waited for treatment for more than two months (M = 43.68). Statistically significant relationships were demonstrated for functional scales and disease intensity. Conclusions: Women diagnosed with breast cancer had a considerably lower overall quality of life. A relatively higher quality of life was experienced by patients who consulted a doctor the earliest after discovering symptoms of the disease and those whose waiting time for treatment was shorter. In a systematic manner, the individual stages of diagnosis should be maximally reduced and breast cancer treatment initiated without delay.
format Online
Article
Text
id pubmed-7696805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76968052020-11-29 Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer Konieczny, Magdalena Cipora, Elżbieta Roczniak, Wojciech Babuśka-Roczniak, Magdalena Wojtaszek, Marek Int J Environ Res Public Health Article Introduction: Breast cancer is the most common malignancy in women. Due to the large number of women living with breast cancer and the increasing incidence of this cancer, it is very important to understand the factors determining the quality of life (QOL) of patients. The aim of the study. The aim of the study was to determine the impact of time to initiation of treatment on the quality of life of women with breast cancer. Materials and methods. The study involved 324 women with breast cancer, treated at the Podkarpackie Oncology Centre in Brzozów, Poland. The study was conducted using a diagnostic survey, using a standardised questionnaire to measure the quality of life of women treated for breast cancer, i.e., the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC) QLQ-C30 and the QLQ-BR23 module, as well as a proprietary survey questionnaire. Statistical analysis was performed using the Statistica 10.0 software (StatSoft Inc., 2011). A p value of <0.05 was considered statistically significant. Results: The examined women had a reduced overall quality of life and health (M = 53.88). The quality of life was higher in women who consulted a doctor the earliest after noticing initial symptoms of the disease, i.e., up to one week (M = 57.58), compared to patients who delayed the decision (over four weeks; M = 47.8) (p = 0.002). The quality of life was also considered higher by women who received treatment within two weeks of diagnosis (M = 56.79) and was lower for patients who waited for treatment for more than two months (M = 43.68). Statistically significant relationships were demonstrated for functional scales and disease intensity. Conclusions: Women diagnosed with breast cancer had a considerably lower overall quality of life. A relatively higher quality of life was experienced by patients who consulted a doctor the earliest after discovering symptoms of the disease and those whose waiting time for treatment was shorter. In a systematic manner, the individual stages of diagnosis should be maximally reduced and breast cancer treatment initiated without delay. MDPI 2020-11-11 2020-11 /pmc/articles/PMC7696805/ /pubmed/33187071 http://dx.doi.org/10.3390/ijerph17228325 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Konieczny, Magdalena
Cipora, Elżbieta
Roczniak, Wojciech
Babuśka-Roczniak, Magdalena
Wojtaszek, Marek
Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title_full Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title_fullStr Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title_full_unstemmed Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title_short Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer
title_sort impact of time to initiation of treatment on the quality of life of women with breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696805/
https://www.ncbi.nlm.nih.gov/pubmed/33187071
http://dx.doi.org/10.3390/ijerph17228325
work_keys_str_mv AT koniecznymagdalena impactoftimetoinitiationoftreatmentonthequalityoflifeofwomenwithbreastcancer
AT ciporaelzbieta impactoftimetoinitiationoftreatmentonthequalityoflifeofwomenwithbreastcancer
AT roczniakwojciech impactoftimetoinitiationoftreatmentonthequalityoflifeofwomenwithbreastcancer
AT babuskaroczniakmagdalena impactoftimetoinitiationoftreatmentonthequalityoflifeofwomenwithbreastcancer
AT wojtaszekmarek impactoftimetoinitiationoftreatmentonthequalityoflifeofwomenwithbreastcancer